bioMérieux announces U.S. FDA-CBER (1) Premarket Notification 510(k) clearance of the recently launched, innovative polycarbonate BacT/ALERT BPA and BacT/ALERT BPN culture bottles for microbial quality control testing of leukocyte-reduced single units of whole blood platelet concentrates (WBPC).

Need information?
CONTACT US
You are here
bioMérieux launches VITEK® 2 Compact, its new solution for rapid identification of micro-organisms
10 February, 2004
bioMérieux, a major player in the field of microbiological controls for the pharmaceutical and agri-food industries, introduces VITEK®2 Compact, the newest addition to its range of automated identification systems.
bioMérieux signs Clinton Foundation initiative on HIV
14 January, 2004
bioMérieux receives CE Mark certification for IVD products marketed in the European Union
08 January, 2004
bioMérieux has received CE Mark certifications for all of its in vitro diagnostic (IVD) products currently marketed in the European Union (EU). In compliance with the requirements of the 98/79/EC directive for CE Marking, which became applicable on December 7th, 2003, these certifications enable bioMérieux to continue to sell its products within the European Union after this date.
Cepheid and bioMérieux enter into strategic commercial program
06 January, 2004
bioMerieux to Apply Cepheid Platform Technology to NASBA Amplification Technology.
Pioneering diagnostics
- Legal Notice
- Privacy
- Cookie Policy
- Contact
- Sitemap
- Copyright 2018 bioMérieux SA